Kowanetz; Marcin
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kowanetz; Marcin.The latest application filed is for "anti-cea immunoconjugates, and uses thereof".
- Kowanetz; Marcin - Redwood City CA
- KOWANETZ; Marcin - San Francisco CA
- Kowanetz; Marcin - South San Francisco CA
| Patent | Date |
|---|---|
| Anti-cea Immunoconjugates, And Uses Thereof App 20220195066 - Ackerman; Shelley Erin ; et al. | 2022-06-23 |
| Immunoconjugates Targeting CEA App 20220152215 - Ackerman; Shelley Erin ; et al. | 2022-05-19 |
| Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions App 20220146517 - KOWANETZ; Marcin ; et al. | 2022-05-12 |
| Therapeutic and diagnostic methods for cancer Grant 11,300,570 - Fabrizio , et al. April 12, 2 | 2022-04-12 |
| Biomarkers and methods of treating PD-1 and PD-L1 related conditions Grant 11,299,544 - Chen , et al. April 12, 2 | 2022-04-12 |
| Therapeutic And Diagnostic Methods For Cancer App 20220073623 - KOWANETZ; Marcin | 2022-03-10 |
| PD-L1 promoter methylation in cancer Grant 11,254,987 - Kadel , et al. February 22, 2 | 2022-02-22 |
| Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions App 20210140967 - KOWANETZ; Marcin ; et al. | 2021-05-13 |
| Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions App 20200333348 - KOWANETZ; Marcin ; et al. | 2020-10-22 |
| Anti-pd-l1 Antibodies And Diagnostic Uses Thereof App 20200270348 - KOWANETZ; Marcin ; et al. | 2020-08-27 |
| Anti-PD-L1 antibodies and diagnostic uses thereof Grant 10,689,445 - Kowanetz , et al. | 2020-06-23 |
| Diagnostic And Therapeutic Methods For Cancer App 20200157635 - KOWANETZ; Marcin ; et al. | 2020-05-21 |
| Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions App 20200041520 - KOWANETZ; Marcin ; et al. | 2020-02-06 |
| Therapeutic And Diagnostic Methods For Cancer App 20200031936 - HEGDE; Priti ; et al. | 2020-01-30 |
| Therapeutic And Diagnostic Methods For Cancer App 20190219586 - Fabrizio; David ; et al. | 2019-07-18 |
| Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions App 20190195882 - KOWANETZ; Marcin ; et al. | 2019-06-27 |
| Methods And Systems For Evaluating Tumor Mutational Burden App 20180363066 - Chalmers; Zachary R. ; et al. | 2018-12-20 |
| Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions App 20180313845 - KOWANETZ; Marcin ; et al. | 2018-11-01 |
| Pd-l1 Promoter Methylation In Cancer App 20180216196 - KADEL; Edward ; et al. | 2018-08-02 |
| Therapeutic And Diagnostic Methods For Cancer App 20180037655 - HEGDE; Priti ; et al. | 2018-02-08 |
| Therapeutic And Diagnostic Methods For Cancer App 20180030138 - KOWANETZ; Marcin | 2018-02-01 |
| Anti-pd-l1 Antibodies And Diagnostic Uses Thereof App 20180022809 - KOWANETZ; Marcin ; et al. | 2018-01-25 |
| Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions App 20170052188 - KOWANETZ; Marcin ; et al. | 2017-02-23 |
| Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions App 20160222118 - CHEN; Daniel Shin-Yu ; et al. | 2016-08-04 |
| Anti-pd-l1 Antibodies And Diagnostic Uses Thereof App 20160009805 - KOWANETZ; Marcin ; et al. | 2016-01-14 |
| Biomarkers And Methods Of Treating Pd-1 And Pd-l1 Related Conditions App 20150071910 - KOWANETZ; Marcin ; et al. | 2015-03-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 